Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Journal of Cardiovascular Pharmacology|December 1, 1990
Effects of a novel Ca2+ entry blocker, CD-349, and TMB-8 on renal vasoconstriction induced by angiotensin II and vasopressin in dogsA Takahara, M Suzuki-Kusaba, H Hisa, et al.
Japanese Journal of Pharmacology|April 28, 2001
Utilization of telemetry system to assess the cardiovascular profile of AH-1058, a new cardioselective Ca2+ channel blocker, in conscious dogsA Takahara, H Dohmoto, R Yoshimoto, et al.
European Journal of Pharmacology|February 15, 2001
Effects of a dual L/N-type Ca(2+) channel blocker cilnidipine on neurally mediated chronotropic response in anesthetized dogsT Konda, A Takahara, K Maeda, et al.
Japanese Journal of Pharmacology|October 23, 1997
Cilnidipine attenuates renal nerve stimulation-induced renal vasoconstriction and antinatriuresis in anesthetized dogsA Takahara, H Dohmoto, H Hisa, et al.
European Journal of Pharmacology|February 15, 2001
Cardiovascular action of a cardioselective Ca(2+)channel blocker AH-1058 in conscious dogs assessed by telemetryA Takahara, H Dohmoto, R Yoshimoto, et al.
Japanese Journal of Pharmacology|August 6, 2000
Electrophysiological and cardiohemodynamic effects of AH-1058, a new type calcium channel blocker, assessed by the in vivo canine modelA Takahara, A Sugiyama, H Dohmoto, et al.
International Journal of Molecular Medicine|April 15, 1999
Pharmacology of N-type Ca2+ channels distributed in cardiovascular system (Review)H Uneyama, A Takahara, M Wakamori, et al.
European Journal of Pharmacology|June 17, 2000
Antiarrhythmic and cardiohemodynamic effects of a novel Ca(2+) channel blocker, AH-1058, assessed in canine arrhythmia modelsA Takahara, A Sugiyama, H Dohmoto, et al.
Japanese Circulation Journal|November 4, 2000
Comparison of the electropharmacological effects of verapamil and propranolol in the halothane-anesthetized in vivo canine model under monophasic action potential monitoringH Shiina, A Sugiyama, A Takahara, et al.
Journal of Cardiovascular Pharmacology|May 17, 2000
Comparison of cardiovascular effects of a new calcium channel blocker AH-1058 with those of verapamil assessed in blood-perfused canine heart preparationsA Takahara, A Sugiyama, H Dohmoto, et al.
Pageof 6